Listen in as our expert panel tackles real-world questions about GLP-1 agonists, from starting them and setting expectations with patients to strategies for switching agents. You’ll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don’t respond to GLP-1 agonists.

Special guests:

• Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, BCACP, CDCES, BC-ADM
  • Clinical Professor and Director of Pharmacy Education
  • University of South Carolina College of Pharmacy
• Jennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADM
  • Professor and the Associate Dean for Education
  • University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

Panelists on TRC’s Editorial Advisory Board:

• Stephen Carek, MD, CAQSM, DipABLM
  • Clinical Associate Professor of Family Medicine
  • Prisma Health/USC-SOMG Family Medicine Residency Program
  • USC School of Medicine Greenville
• Craig D. Williams, PharmD, FNLA, BCPS
  • Clinical Professor of Pharmacy Practice
  • Oregon Health and Science University

For the purposes of disclosure Dr. Jennifer Clements reports relevant financial relationships with Novo Nordisk (Ozempic, Rybelsus), Eli Lilly (Zepbound, tirzepatide) [speakers bureau].

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in February 2026.

🏷️ Use code mt1026 at checkout for 10% off.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

Clinical Resources:

• Comparison of GLP-1 and GIP/GLP-1 Receptor Agonists
• GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
• Comparison of Weight Loss Products
• Improving Diabetes Outcomes
• Diabetes Medications: Cardiovascular and Kidney Impact

Send us Fan Mail

Email us: ContactUs@trchealthcare.com.

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.

Listen in as our expert panel reviews important concepts behind antimicrobial stewardship along with tips to help limit unnecessary antimicrobial use.

Special guests:

• Madeline King, PharmD, MPH, BCIDP
  • Co-Director, Outpatient Antimicrobial Stewardship
  • Cooper University Health Care
  • Assistant Professor of Medicine
  • Cooper Medical School at Rowan University
• Michael A. Deaney, PharmD, AAHIVP
  • Infectious Diseases Clinical Pharmacy Specialist
  • Denver Health & Hospital Authority

You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:

• Stephen Carek, MD, CAQSM, DipABLM
  • Clinical Associate Professor of Family Medicine
  • Prisma Health/USC-SOMG Family Medicine Residency Program
  • USC School of Medicine Greenville
• Craig D. Williams, PharmD, FNLA, BCPS
  • Clinical Professor of Pharmacy Practice
  • Oregon Health and Science University

For the purposes of disclosure, Dr. Madeline King reports a relevant financial relationship with Shionogi (speakers bureau for cefiderocol).

The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in January 2026.

Use code mt1026 at checkout for 10% off a new or upgraded subscription.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources related to this podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Toolbox: Antimicrobial Stewardship
• Algorithm: Investigating Possible Drug Allergy
• CE Course: Implementing Rapid Diagnostic Testing
• Chart: Antibiotic Therapy: When Are Shorter Courses Better?

Send a text

*****

📣 New Podcast!📣

🌱Natural Medicines: Evidence in Practice

Evidence, not hype. Concise, clinician‑ready guidance on natural medicines and integrative care. Episode 1: GLP‑1s & Nutrition is live now!

*****

Email us: ContactUs@trchealthcare.com.

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.

In this bonus episode of Medication Talk, join us as we revisit our Notable New Meds of 2025 webinar and highlight two medications that didn’t make it into the main podcast—both newly approved antibiotics with important implications for clinical practice.

Listen in as our editors take a deeper look at:

• Gepotidacin (Blujepa) for uncomplicated urinary tract infections
• Aztreonam/avibactam (Emblaveo) for complicated intraabdominal‑abdominal infections

You’ll hear practical insights into where these therapies fit in current treatment approaches, what safety and interaction issues to watch for, and why they matter when resistance limits your options—giving you more confidence when either of these new meds show up in your practice.

**No CE Credit is available for this bonus episode.**

Use code mt1026 at checkout for 10% off a new or upgraded subscription.

******

TRC Healthcare Editors:

• Sara Klockars, PharmD, BCPS
• Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC

None of the speakers have anything to disclose.

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in December 2025.

The clinical resources related to this podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Chart: Urinary Tract Infections
• Chart: Aztreonam-avibactam (Emblaveo)
• Article: Keep Boosting Antibiotic Stewardship for Complicated UTIs

Send a text

*****

📣 New Podcast!📣

🌱Natural Medicines: Evidence in Practice

Evidence, not hype. Concise, clinician‑ready guidance on natural medicines and integrative care. Episode 1: GLP‑1s & Nutrition is live now!

*****

Email us: ContactUs@trchealthcare.com.

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.